About Moderna

Moderna develops mRNA medicines that prompt the immune system to create the tools needed to treat or prevent disease. This approach represents a fundamental shift from traditional medicine, using messenger RNA that already exists in the body to carry instructions that direct cells what to do. The platform enables rapid design, research and testing of therapies within days. The company operates across infectious diseases, oncology, rare diseases and cardiovascular conditions. With 45 development programmes and 36 ongoing clinical trials, Moderna delivers treatments for diseases that currently have no solutions. This biotechnology platform combines scientific precision with speed, turning what once took years into processes measured in days.